Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

Neurology's 63rd Annual Meeting. Two pivotal Phase 3 studies investigating alemtuzumab, CARE-MS I and II, are currently ongoing. Top-line results from these trials are expected to be available early in the third quarter of 2011 and in the fourth quarter of 2011. The company expects to file for U.S. and EU approval in early 2012, and has been granted fast track status by the FDA.

Genzyme and Isis Pharmaceuticals Inc. announced in April that data from two phase 3 studies of mipomersen in patients who had high cholesterol levels while on lipid-lowering therapy were presented at the American College of Cardiology. In the study in patients with severe heterozygous familial hypercholesterolemia, mipomersen reduced LDL-C, the primary endpoint, by 36% compared with a 13% increase for placebo (p<0.001). Frequently observed adverse events were injection site reactions, flu-like symptoms and elevations in liver transaminases, as seen in previous studies.

Results of a Phase 3 study of mipomersen in patients with high cholesterol at high risk for CHD were also presented in a poster at American College of Cardiology. In this study, mipomersen reduced LDL-C, the primary endpoint, by 37% compared with a 5% reduction for placebo (p<0.001). Genzyme expects to file for EU marketing approval of mipomersen for the treatment of patients with hoFH (homozygous familial hypercholesterolemia) and severe heFH (heterozygous familial hypercholesterolemia) early Q3 2011. Genzyme also expects to file for U.S. approval for the hoFH indication in second half of this year.

In March, sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced results from the Phase III VITAL trial evaluating aflibercept for the second-line treatment of non-small cell lung cancer. The data showed that adding aflibercept to the chemotherapy drug docetaxel did not meet the pre-specified criteria for the primary endpoint of improvement in overall survival compared with a regimen
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... , Aug. 29, 2014  In part ... to leverage a hospital pharmacy as a strategic asset, ... national practice leader for Cardinal Health,s Innovation Delivery Solutions ... care can benefit both hospitals and patients. ... only one part of their job in a value-based ...
(Date:8/29/2014)... Pixcelldata, the innovative Irish developer of digital ... new deal with Dutch based eX-Path, global providers of ... Marius Nap . The announcement was made ... which is taking placing between August 30th and September ... where Pixcelldata will demonstrate its innovative solution. ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
(Date:9/1/2014)... Tampa, FL (PRWEB) September 02, 2014 ... dedicated exclusively to root canal therapy based in Tampa, ... August. The website features helpful information aimed at making ... also has an eye-catching design featuring updated images that ... was to make our website experience just as pleasant ...
(Date:9/1/2014)... PAINWeek, the National Conference on Pain for ... (APS) will return to the conference for the 3rd ... to the agenda. This activity is open to local ... this program. , On Thursday, September 4, the APS ... the FDA’s Risk Evaluation and Mitigation Strategies (REMS) for ...
(Date:9/1/2014)... UWDress.com, a well-known wedding dress manufacturer ... lime green bridesmaid dresses for its new and ... the company’s online category. What’s more, they are offered ... special offer is specially launched to celebrate the coming ... gowns have won great appreciation from worldwide clients. Now, ...
(Date:9/1/2014)... regular family meals may help protect teens from the ... suggests. Online abuse can lead to depression, anxiety ... five adolescents experience cyberbullying," Frank Elgar, a professor at ... University in Montreal, said in a university news release. ... and abuse are difficult for parents and educators to ...
(Date:9/1/2014)... -- You may be able to convince your brain that ... The study included eight overweight and obese people who ... change how people react to different foods. These participants were ... people who weren,t in the program. Both groups had ... again six months later. The scans revealed that the people ...
Breaking Medicine News(10 mins):Health News:Citrus Park Endodontics Launches New Website to Better Serve Patients 2Health News:American Pain Society Returns with REMS Training at PAINWeek 2014 in Las Vegas 2Health News:2014 Lime Green Bridesmaid Dresses Offered At UWDress.com 2Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2
... Families with Uninsured Children to Non-Profit Agencies Assisting with Enrollment into State-Sponsored Health Coverage Programs , ... , , ... ... ...
... ... ... Tahitian Noni International (TNI) announced that their flagship product will no longer be called ... Although the name is changing, Tahitian Noni Original is the same authentic bioactive beverage that ...
... Dr. Glen ... ... Autism is an exceptionally complex illness. Autism is a developmental disorder with impairments in ... 1 in every 150 children in the United States is now diagnosed with the illness, ...
... ... ingredients to its already popular product to make it the complete skin care formula. ... (PRWEB) March 16, 2010 -- ... , , ,Age spots, liver spots, brown patches, freckles, acne scars and uneven skin tone ...
... ... (EDS) announces the introduction of the SafeSiders Glide Path Kit. Designed specifically to create ... compatible with ANY instrumentation system., , ... (PRWEB) March 16, 2010 -- Essential Dental Systems, Inc. (EDS) announces ...
... ... earn a reliable residual income in the current economy, and who are looking to better ... Aspin. Aspin is currently enlisting interested business leaders nationwide., , ... (PRWEB) March 16, 2010 -- Independent businessman Brad Aspin and ...
Cached Medicine News:Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 2Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 3Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 4Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 5Health News:Tahitian Noni Juice Is Now Tahitian Noni Original Bioactive Beverage 2Health News:Autism Research Study Announced By Children's Health Council 2Health News:Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients 2Health News:Brad Aspin and Health and Wellness Company GBG Now Looking for Leaders Nationwide 2
Designed for simple operation, the Model 515C pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
... N-20PA Handheld Pulse Oximeter is a one-of-a-kind ... construction of the N-20PA has been shock-tested, ... conditions it has even withstood the ... portable for spot check measurements and also ...
Medicine Products: